Bovine serum-derived immunoglobulins (IgG) support gut immunity and barrier function.





Serum-derived bovine immunoglobulins (SBI) provide concentrated IgG antibodies that bind pathogens, toxins, and antigens in the gut. They help reduce inflammation and support the gut barrier without altering microbiome composition.
People with chronic gut symptoms (IBS-D, IBD, post-infectious gut issues), food sensitivities, or compromised barrier function. Studies show benefit for diarrhea-predominant IBS and HIV-associated enteropathy.
Both contain IgG, but colostrum is from cow first-milk and includes growth factors and other bioactives at lower IgG concentration. SBI products are concentrated to about 50% IgG. Colostrum is broader-spectrum and gentler; SBI is more targeted and higher dose. They can be used together.
Often yes. By binding antigens before they reach immune cells in the gut, SBI can reduce reactive symptoms. Studies and clinical reports show improvements in IBS-D, food-triggered fatigue, and brain fog. It works best alongside elimination of identified triggers.
Most people notice changes within 2–4 weeks (looser stools improving, less bloating). Full benefits develop over 8–12 weeks. If no benefit by 8 weeks, the dose is likely too low or the symptom isn't IgG-responsive.
Yes, technically. Serum-derived bovine immunoglobulin is from blood serum, not milk, so it contains no lactose or casein. It's safe for people with dairy allergies who are not specifically allergic to bovine plasma proteins.
Yes, it has a strong safety profile and can be taken indefinitely. Many people use a higher therapeutic dose for 2–3 months, then maintain at a lower dose. It doesn't cause tolerance or dependence.